1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market: Forecasts until 2021

  • January 2017
  • 144 pages
  • ID: 4666418
In this report:
In 2016, non-benzodiazepines sleep aids segment is expected to account for the largest share of ##.##% of prescription sleep aids market for insomnia in the U.S. The sales of this segment are expected to decline to USD ##.## million by 2021 from USD ##,##.## million, at a negative CAGR of ##.##% during the forecast period (2016-2021).

Summary

Table of Contents

Search Inside

The U.S. insomnia market is estimated to grow ~$4.2B by 2021 from ~$3.4B in 2016, increasing at a compound annual growth rate (CAGR) of 4.60 percent from 2016 to 2021

In 2016, the cognitive behavioural therapy for insomnia segment is planned to account for the biggest share of the market. The other alternative therapies contain exercise/yoga, acupuncture, biofeedback, bright light therapy, music therapy, and aroma therapy.

In 2016, the prescription sleep aids segment is intended to account for the biggest share of the U.S. insomnia pharmacological treatment market. The launch of Belsomra in 2014 in the U.S. and the anticipated launch of E-2006 is predicted to push the increase of the market during the forecast years. On the other hand, due to the erosion in branded drugs sales and increasing adoption of generics attributed to their low cost and equal efficacy as distinguished to branded products may hinder the market increase. In 2016, the zolpidem segment is forecasted to account for the most important share of the non-benzodaizepines prescription sleep aids market. Nevertheless, higher adoption of generic products that are available are cheaper price is negatively affecting the increase of the market.

The over-the-counter sleep aids segment of the U.S. insomnia pharmacological treatment market is anticipated to rise at the highest CAGR (Compound annual growth rate) during the estimate period. Reasons attributing to the rise of this market contain easier availability, low prices, and publicity concerning the side effects of the prescription sleep aids has also steered the patients towards OTC sleep aid. In 2016, the antihistamines sleep aids segment is forecasted to hold the biggest share of the over-the-counter sleep aids market, because, melatonin is anticipated to grow at the highest compound annual growth rate (CAGR) during the outlook period. Increasing awareness about the advantages of melatonin including least amount of side effects, reduces stress levels, and its increasing consumption is driving the increase of this segment in the U.S.A

Some of the top players offering insomnia treatment contain Eisai, Co. Ltd., Merck & Co., Incorporated, Meda Consumer Healthcare Inc., Pfizer, Incorporated, Sanofi, Takeda Pharmaceutical Company Ltd., Pernix Therapeutics, and Purdue Pharma L.P..

Segment Research

The market study includes the U.S. insomnia market, by type of treatment, to estimate the total market size during 2013 to 2021. This business report also includes the drivers, market restraints, and opportunities of the market together with the competitive landscape of the U.S. insomnia market actors.

Why acquiring this study can help you:

The study will increase both established firms as well as new entrants/smaller companies to measure the pulse of the sector, which in turn benefits organizations to collect a larger market share. Companies obtaining the analysis could use any one or an aggregation of the below-mentioned five strategies (sector entry, product improvement/innovative projects, industry development, business diversification, and opposing assessment) for strengthening their market shares.

This study furnishes highlights on the following points:

- Business entry: Comprehensive information regarding products and services provided by the top actors in the U.S. insomnia market

- Product improvement/Innovative products: In-depth understanding on analysis & growth activities, and recent product launches in the U.S. insomnia market

- Industry diversification: Complete information about recent products, recent evolutions, and market investments in the U.S. insomnia market

- Opposing assessment: Detailed assessment of strategies, products, and pipeline products of the main actors in the U.S. insomnia market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Sleep Aids in Canada

Sleep Aids: In-depth Industry Report in Canada

  • $ 992
  • Industry report
  • October 2017
  • by Euromonitor International

Sleep aids in Canada is projected to record a healthy retail value CAGR at constant 2017 prices over the forecast period. Many Canadians experience sleep problems due to stressful modern lifestyles and ...

Sleep Aids in Italy

Sleep Aids: In-depth Industry Report in Italy

  • $ 992
  • Industry report
  • October 2017
  • by Euromonitor International

Rising urbanisation with increasingly busy and noisy cities, increasing hectic lifestyles and rising stress levels will continue contributing to the incidence of sleep disorders in Italy.According to EuroDap, ...

Sleep Aids in China

Sleep Aids: In-depth Industry Report in China

  • $ 992
  • Industry report
  • October 2017
  • by Euromonitor International

In 2017, sleep aids in China continued to record double-digit current value growth, in line with both the previous year and the review period average. Ongoing strong growth can be attributed to the combined ...


Download Unlimited Documents from Trusted Public Sources

Global OTC Markets

  • December 2017
    28 pages
  • OTC  

  • China  

    Australia  

View report >

OTC Markets in the UK and Europe

  • November 2017
    40 pages
  • OTC  

    Smoking Statist...  

    Herbal Suppleme...  

  • United Kingdom  

    Europe  

    World  

View report >

OTC Markets in the UK

  • October 2017
    6 pages
  • OTC  

  • United Kingdom  

View report >

OTC Markets in Europe 11 months ago


Related Market Segments :

Sleep Aid

Pharmaceutical

Therapy

ref:plp2017

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.